首页> Multiple sclerosis (Houndmills, Basingstoke, England)> Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study.

Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study.

导出 OA

翻译打印收藏纠错

第一作者： Gavin,Giovannoni

第一单位： Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

作者： Gavin,Giovannoni ^[1] ; Alexey,Boyko ^[2] ; Jorge,Correale ^[3] ; Gilles,Edan ^[4] ; Mark S,Freedman ^[5] ; Xavier,Montalban ^[6] ; Kottil,Rammohan ^[7] ; Dusan,Stefoski ^[8] ; Bassem,Yamout ^[9] ; Thomas,Leist ^[10] ; Aida,Aydemir ^[11] ; Laszlo,Borsi ^[12] ; Elisabetta,Verdun di Cantogno ^[11]

作者单位： Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. ^[1] Department of Neurology, Neurosurgery and Medical Genetics, Federal Center of Brain Research and Neurotechnologies, Pirogov Russian National Research Medical University, Moscow, Russia. ^[2] Department of Neurology, FLENI Institute, Buenos Aires, Argentina. ^[3] Department of Neurology, University Hospital of Rennes, Rennes, France. ^[4] Department of Medicine and the Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada. ^[5] Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d'Hebron, Barcelona, Spain. ^[6] MS Research Center, School of Medicine, University of Miami, Miami, FL, USA. ^[7] Department of Neurological Sciences, Rush Medical College, Chicago, IL, USA. ^[8] Neurology Institute, Harley Street Medical Center, Abu Dhabi, UAE/American University of Beirut Medical Center, Beirut, Lebanon. ^[9] Division of Clinical Neuroimmunology, Comprehensive MS Center, Jefferson University, Philadelphia, PA, USA. ^[10] EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA. ^[11] Merck Healthcare KGaA, Darmstadt, Germany. ^[12]

关键词 CLARITY CLARITY Extension Cladribine tablets Expanded Disability Status Scale disability disease-modifying therapy employment multiple sclerosis